Fexofenadine Supplier-Buyer Network — Trade Flow Analysis

Name: Fexofenadine Supplier-Buyer Trade Network Dataset — 224+ Indian Exporters, 22+ Importers, 97+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Fexofenadine supplier network, Fexofenadine buyers, pharmaceutical export India, Fexofenadine trade data

TransData Nexus

Fexofenadine

India Pharmaceutical Trade Intelligence

$109.6M224 Suppliers97 CountriesHS 30049039

ExportsIndia → UNITED KINGDOM30.8%India → UNITED STATES26.9%

ImportsSINGAPORE → India$150.2K BRAZIL → India$14.3K

#1 Supplier: GRANULES INDIA

Who Supplies Fexofenadine? Top Manufacturers & Buyers 2026 — GRANULES INDIA LIMITED Leads | TransData Nexus | TransData Nexus

1GRANULES INDIA LIMITED

GRANULES INDIA LIMITED is the first-largest Fexofenadine exporter from India, with a market share of 13.2% and a total export value of $14.4M across 194 shipments. Their average shipment value of $74.5K is above the market average of $25.9K, suggesting premium or bulk contract pricing.

GRANULES INDIA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• GRANULES CONSUMER HEALTH — $5.8M across 78 shipments (40.4% of this supplier's total exports)

• GRANULES USA INC — $5.1M across 69 shipments (35.7% of this supplier's total exports)

• GRANULES USA INC — $3.0M across 40 shipments (20.8% of this supplier's total exports)

• GRANULES CONSUMER — $266.2K across 4 shipments (1.8% of this supplier's total exports)

• GRANULES CONSUMER HEALTH — $195.8K across 3 shipments (1.4% of this supplier's total exports)

Key Insight: GRANULES INDIA LIMITED's per-shipment value of $74.5K is 188% above the market average of $25.9K, consistent with large-order contracts or value-added formulations.

2CIPLA LIMITED

CIPLA LIMITED is the second-largest Fexofenadine exporter from India, with a market share of 9.1% and a total export value of $10.0M across 921 shipments. Their average shipment value of $10.8K is below the market average of $25.9K, reflecting a high-volume, competitive pricing strategy.

CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• H.ESSERS & ZONEN INTERNATIONAL TRAN — $3.9M across 362 shipments (39.3% of this supplier's total exports)

• ALLOGA UK LTD — $3.6M across 336 shipments (36.5% of this supplier's total exports)

• NOUMED PHARMACEUTICALS PTY LTD — $1.9M across 177 shipments (19.2% of this supplier's total exports)

• BREATHEFREE LANKA PV — $288.7K across 27 shipments (2.9% of this supplier's total exports)

• NOUMED PHARMACEUTICALS PTY LTD — $204.0K across 19 shipments (2.0% of this supplier's total exports)

Key Insight: CIPLA LIMITED operates with high shipment frequency (921 shipments) at a per-shipment value of $10.8K, indicating a broad distribution network with many smaller, regular orders.

3DR.REDDY'S LABORATORIES LTD

DR.REDDY'S LABORATORIES LTD is the third-largest Fexofenadine exporter from India, with a market share of 8.8% and a total export value of $9.6M across 249 shipments. Their average shipment value of $38.7K is above the market average of $25.9K, suggesting premium or bulk contract pricing.

DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. MOVIANTO UK LTD is the dominant customer, accounting for 78.5% of this supplier's tracked business. Top customers include:

• MOVIANTO UK LTD — $7.6M across 195 shipments (78.5% of this supplier's total exports)

• MOVIANTO UK LTD — $1.7M across 44 shipments (17.7% of this supplier's total exports)

• REED - LANE INC 359 — $220.1K across 6 shipments (2.3% of this supplier's total exports)

• DR.REDDY'S LABORATOR — $88.6K across 2 shipments (0.9% of this supplier's total exports)

• DR.REDDYS NEWZEALAND — $56.5K across 1 shipments (0.6% of this supplier's total exports)

Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $38.7K is 50% above the market average of $25.9K, consistent with large-order contracts or value-added formulations.

4IND SWIFT LIMITED

IND SWIFT LIMITED is the fourth-largest Fexofenadine exporter from India, with a market share of 7.4% and a total export value of $8.1M across 524 shipments. Their average shipment value of $15.5K is below the market average of $25.9K, reflecting a high-volume, competitive pricing strategy.

IND SWIFT LIMITED serves 5 named buyers in our database. CHANELLE MEDICAL is the dominant customer, accounting for 68.1% of this supplier's tracked business. Top customers include:

• CHANELLE MEDICAL — $5.5M across 357 shipments (68.1% of this supplier's total exports)

• APOTEX PTY LTD — $1.0M across 66 shipments (12.6% of this supplier's total exports)

• KENT PHARMA UK LTD — $686.1K across 44 shipments (8.4% of this supplier's total exports)

• ASCEND LABORATORIES — $572.4K across 37 shipments (7.0% of this supplier's total exports)

• GOLDPLUS UNIVERSAL P — $305.5K across 20 shipments (3.8% of this supplier's total exports)

Key Insight: IND SWIFT LIMITED operates with high shipment frequency (524 shipments) at a per-shipment value of $15.5K, indicating a broad distribution network with many smaller, regular orders.

5DR REDDYS LABORATORIES LIMITED

DR REDDYS LABORATORIES LIMITED is the fifth-largest Fexofenadine exporter from India, with a market share of 5.4% and a total export value of $5.9M across 62 shipments. Their average shipment value of $94.7K is above the market average of $25.9K, suggesting premium or bulk contract pricing.

DR REDDYS LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MOVIANTO UK LIMITED — $2.7M across 28 shipments (46.0% of this supplier's total exports)

• DR REDDYS LABORATORIES INC — $1.9M across 20 shipments (32.7% of this supplier's total exports)

• REED-LANE INC — $691.5K across 7 shipments (11.8% of this supplier's total exports)

• MOVIANTO UK LTD — $412.1K across 4 shipments (7.0% of this supplier's total exports)

• REED-LANE INC — $149.3K across 2 shipments (2.5% of this supplier's total exports)

Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $94.7K is 266% above the market average of $25.9K, consistent with large-order contracts or value-added formulations.

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Fexofenadine exporter from India, with a market share of 5.3% and a total export value of $5.8M across 154 shipments. Their average shipment value of $37.8K is above the market average of $25.9K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• OHM LABORATORIES INC — $2.0M across 52 shipments (33.5% of this supplier's total exports)

• AO RANBAXY — $1.4M across 38 shipments (24.6% of this supplier's total exports)

• OHM LABORATORIES INC — $1.1M across 29 shipments (18.9% of this supplier's total exports)

• AO RANBAXY — $813.0K across 21 shipments (14.0% of this supplier's total exports)

• M/S. RANBAXY FARMACE — $527.7K across 14 shipments (9.1% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $37.8K is 46% above the market average of $25.9K, consistent with large-order contracts or value-added formulations.

1United Kingdom

United Kingdom ranks as the first-largest destination for Fexofenadine imports from India, with a total trade value of $33.8M across 691 shipments — representing a 30.8% share of all Fexofenadine exports. The average shipment value of $48.9K is above the global average of $25.9K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Fexofenadine importers in United Kingdom: MOVIANTO UK LTD is the largest buyer, accounting for 32.6% ($11.0M) of this market's total imports.

• MOVIANTO UK LTD — $11.0M (32.6% of United Kingdom's total)

• MOVIANTO UK LIMITED — $5.4M (16.1% of United Kingdom's total)

• ALLOGA UK LTD — $4.3M (12.6% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $48.9K (89% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Fexofenadine imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Fexofenadine imports from India, with a total trade value of $29.5M across 271 shipments — representing a 26.9% share of all Fexofenadine exports. The average shipment value of $108.9K is above the global average of $25.9K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.

Named Fexofenadine importers in United States: GRANULES USA INC is the largest buyer, accounting for 25.2% ($7.4M) of this market's total imports.

• GRANULES USA INC — $7.4M (25.2% of United States's total)

• GRANULES CONSUMER HEALTH — $5.8M (19.8% of United States's total)

• GRANULES USA INC. — $3.3M (11.3% of United States's total)

Key Insight: United States's per-shipment average of $108.9K (321% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Fexofenadine imports from India.

Primary Market

Secondary Market

3Ireland

Ireland ranks as the third-largest destination for Fexofenadine imports from India, with a total trade value of $11.0M across 358 shipments — representing a 10.0% share of all Fexofenadine exports. The average shipment value of $30.6K is above the global average of $25.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Fexofenadine importers in Ireland: CHANELLE MEDICAL is the largest buyer, accounting for 95.5% ($10.5M) of this market's total imports.

• CHANELLE MEDICAL — $10.5M (95.5% of Ireland's total)

Key Insight: Ireland's per-shipment average of $30.6K (18% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ireland is a key market for Fexofenadine imports from India.

Primary Market

Secondary Market

4Australia

Australia ranks as the fourth-largest destination for Fexofenadine imports from India, with a total trade value of $8.8M across 366 shipments — representing a 8.1% share of all Fexofenadine exports. The average shipment value of $24.1K is below the global average of $25.9K, consistent with generic/API volume purchasing. This market is served by 3 tracked buyers.

Named Fexofenadine importers in Australia: NOUMED PHARMACEUTICALS PTY LTD is the largest buyer, accounting for 31.6% ($2.8M) of this market's total imports.

• NOUMED PHARMACEUTICALS PTY LTD — $2.8M (31.6% of Australia's total)

• MEDREICH AUSTRALIA PTY LTD — $1.4M (15.5% of Australia's total)

• APOTEX PTY LTD — $1.3M (14.7% of Australia's total)

Key Insight: Australia receives frequent, smaller shipments of Fexofenadine — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Australia is a key market for Fexofenadine imports from India.

Primary Market

Secondary Market

5Belgium

Belgium ranks as the fifth-largest destination for Fexofenadine imports from India, with a total trade value of $5.0M across 166 shipments — representing a 4.6% share of all Fexofenadine exports. The average shipment value of $30.2K is above the global average of $25.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Fexofenadine importers in Belgium: H.ESSERS & ZONEN INTERNATIONAL TRAN is the largest buyer, accounting for 84.5% ($4.2M) of this market's total imports.

• H.ESSERS & ZONEN INTERNATIONAL TRAN — $4.2M (84.5% of Belgium's total)

Key Insight: Belgium's per-shipment average of $30.2K (17% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Fexofenadine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Fexofenadine.
2.Flow Mapping: 224 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,236 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 97 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4,236 Verified Shipments

224 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Fexofenadine

Fexofenadine

Who Supplies Fexofenadine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Fexofenadine — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Fexofenadine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Fexofenadine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1GRANULES INDIA LIMITED

2CIPLA LIMITED

3DR.REDDY'S LABORATORIES LTD

4IND SWIFT LIMITED

5DR REDDYS LABORATORIES LIMITED

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

From Indian Factories to Global Pharmacies — How Fexofenadine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Fexofenadine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United Kingdom

2United States

3Ireland

4Australia

5Belgium

People Also Ask — Fexofenadine Supplier & Trade Network

Fexofenadine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology